PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25522687-0 2015 Cholesterol-mediated surfactant dysfunction is mitigated by surfactant protein A. Cholesterol 0-11 surfactant protein A1 Homo sapiens 60-80 25522687-3 2015 It was hypothesized that elevated cholesterol levels within surfactant inhibit human surfactant biophysical function and that these effects can be reversed by surfactant protein A (SP-A). Cholesterol 34-45 surfactant protein A1 Homo sapiens 159-179 25522687-3 2015 It was hypothesized that elevated cholesterol levels within surfactant inhibit human surfactant biophysical function and that these effects can be reversed by surfactant protein A (SP-A). Cholesterol 34-45 surfactant protein A1 Homo sapiens 181-185 25522687-8 2015 It is concluded that cholesterol-induced surfactant inhibition can actively contribute to physiological impairment of the lungs in mechanically ventilated patients and that SP-A levels may be important to maintain surfactant function in the presence of high cholesterol within surfactant. Cholesterol 258-269 surfactant protein A1 Homo sapiens 173-177 9548588-0 1998 Interaction of pulmonary surfactant protein A with dipalmitoylphosphatidylcholine and cholesterol at the air/water interface. Cholesterol 86-97 surfactant protein A1 Homo sapiens 15-45 9548588-1 1998 Interaction of pulmonary surfactant protein A (SP-A) with pure and binary mixed dipalmitoylphosphatidylcholine (DPPC) and cholesterol (3.5 wt%) at the air/saline, 1.5 mM CaCl2 interface was investigated using a rhomboid surface balance at 37 degrees C. Surface tension-area isotherms were measured to access the surface active properties of the monolayers. Cholesterol 122-133 surfactant protein A1 Homo sapiens 15-45 9548588-1 1998 Interaction of pulmonary surfactant protein A (SP-A) with pure and binary mixed dipalmitoylphosphatidylcholine (DPPC) and cholesterol (3.5 wt%) at the air/saline, 1.5 mM CaCl2 interface was investigated using a rhomboid surface balance at 37 degrees C. Surface tension-area isotherms were measured to access the surface active properties of the monolayers. Cholesterol 122-133 surfactant protein A1 Homo sapiens 47-51 9548588-5 1998 SP-A also reduced the collapse surface tension of pure cholesterol from 27 to 23 mN/m. Cholesterol 55-66 surfactant protein A1 Homo sapiens 0-4 9548588-8 1998 Although SP-A could not promote the squeeze-out of cholesterol from homogeneous mixed monolayers, it facilitated that of cholesterol domains especially when SP-A had first interacted with DPPC. Cholesterol 121-132 surfactant protein A1 Homo sapiens 9-13 9548588-9 1998 These results indicate that pulmonary surfactant protein A facilitates the squeeze-out of cholesterol domains from mixed monolayers by condensing DPPC and limiting lateral interactions of DPPC with cholesterol domains. Cholesterol 90-101 surfactant protein A1 Homo sapiens 28-58 9548588-9 1998 These results indicate that pulmonary surfactant protein A facilitates the squeeze-out of cholesterol domains from mixed monolayers by condensing DPPC and limiting lateral interactions of DPPC with cholesterol domains. Cholesterol 198-209 surfactant protein A1 Homo sapiens 28-58 8004321-6 1994 We found a direct relationship between CHOL and DSP (rs = 0.84, p < 0.001), SP-A and CHOL (rs = 0.40, p < 0.025), and between SP-A and DSP (rs = 0.44, p < 0.025). Cholesterol 88-92 surfactant protein A1 Homo sapiens 79-83 16489761-8 2006 Incorporation of cholesterol into J5 LPS/POPE liposomes at a POPE:cholesterol molar ratio of 1:0.15 blocked human SP-A or melittin-induced permeability (p < 0.05) compared to cholesterol-free liposomes. Cholesterol 17-28 surfactant protein A1 Homo sapiens 114-118 16489761-11 2006 Incorporation of cholesterol into the membrane enhances resistance to permeabilization by SP-A, most likely by increasing the packing density and membrane rigidity. Cholesterol 17-28 surfactant protein A1 Homo sapiens 90-94